What’s the difference between ichorbio and Bio X Cell?
First, we’d just like to give a quick nod to the team at Bio X Cell. They’ve built a brilliant company with great products to help life science researchers.
The founding team at ichorbio wanted to create a company where our main focus is to supply products that have the lowest impact on the animals that they are used in.
For us, the welfare of the animals used for in vivo research is the *key* consideration all researchers should take into consideration before beginning their experiments.
So when we created the company our focus was on creating the highest quality reagents in the industry, and it is our belief that the products we created will directly impact the quality of the results obtained from them.
Looking at the 3Rs, our hope is that our products can improve animal welfare as follows.
01
Refinement
We have made incremental improvements to the purity of our antibodies over those currently in the market and have also worked hard to reduce their aggregation. Both of these attributes should will help in the Refinement of your animal studies by allowing our antibodies antibodies to act with greater efficacy.
02
Reduction
Our antibodies have the lowest endotoxin on the market which will help with Reduction by positively affecting the wellbeing of your animals. Manufacturing in a ISO9001, GMP certified facility ensures our customers experience minimal lot to lot variability and improved reproducibility – again helping with the Reduction of the number of animals used in your research.
Formulations Side by Side
Low Endotoxin
ichorbio Low |
Bio X Cell InVivoMab™ |
|
Endotoxin |
<1 EU/mg |
<2 EU/mg |
Purity |
>95% |
>95% |
Aggregation |
<5% |
N/A |
Facility |
cGMP compliant, ISO Quality Standard 9001:2015 |
Animal free facility |
Ultra-Low Endotoxin
ichorbio Ultra-Low Endotoxin Antibodies |
Bio X Cell InVivoPlus™ |
|
Endotoxin |
<0.5 EU/mg |
<1 EU/mg |
Purity |
>98% |
>95% |
Facility |
cGMP compliant, ISO Quality Standard 9001:2015 |
Animal free facility |
Pathogen Free |
Tested with IDEXX BioResearch's IMPACT test |
Tested with IDEXX BioResearch's IMPACT test |
Academia Pricing
The data shown below are the standard prices listed on the Bio X Cell website and do not include any special offers they may provide from time to time. ichorbio’s antibodies are 6% less on average for Low Endotoxin versions compared for these antibodies, with a maximum difference of 12%.
Bio X Cell’s best selling antibodies:
- anti-CTLA-4 antibody, clone 9D9
- anti-CTLA-4 antibody, clone 9H10
- anti-PD-L1 antibody, clone 10F.9G2
- anti-PD-1 antibody, clone RMP1-14
ichorbio’s antibodies are 6% less on average for Low Endotoxin versions compared for these antibodies, with a maximum difference of 12%.
Size |
ichorbio Low Endotoxin Antibodies |
Bio X Cell InVivoMAb™ Antibodies |
% Savings |
5mg |
$380 |
$390 |
3% |
25mg |
$1260 |
$1305.85 |
4% |
50mg |
$2010 |
$1965.60 |
-2% |
100mg |
$2830 |
$2782 |
-2% |
ichorbio’s antibodies are 6% less on average for Ultra-Low Endotoxin versions compared with Bio X Cell, with a maximum of 7%.
Size |
ichorbio Ultra Low Endotoxin Antibodies |
Bio X Cell InVivoPlus™ Antibodies |
% Saving |
5mg |
$500 |
$507.65 |
2% |
25mg |
$1710 |
$1699.75 |
-1% |
50mg |
$2530 |
$2558.40 |
1% |
100mg |
$3630 |
$3619.20 |
0% |
ichorbio's RMP1-14 antibody is 75% less than Bio X Cell on average, with a maximum difference of 101%.
Size |
ichorbio's RMP1-14 Antibody |
Bio X Cell's RMP1-14 Antibody |
% Saving |
5mg |
$250 |
$411.45 |
39% |
25mg |
$700 |
$1405.30 |
50% |
50mg |
$1200 |
$2702.20 |
42% |
100mg |
$1800 |
$2895.75 |
38% |
Size |
ichorbio Low Endotoxin Antibodies |
Best Selling Bio X Cell InVivoMAb™ Antibodies |
% Savings |
5mg |
$370 |
$411.45 |
10% |
25mg |
$1140 |
$1405.30 |
19% |
50mg |
$1860 |
$2072.20 |
10% |
100mg |
$2600 |
$2895.75 |
10% |
Size |
ichorbio Ultra-Low Endotoxin Antibodies |
Best Selling Bio X Cell InVivoPlus™ Antibodies |
% Savings |
5mg |
$500 |
$535.60 |
7% |
25mg |
$1710 |
$1827.80 |
6% |
50mg |
$2530 |
$2696.85 |
8% |
100mg |
$3630 |
$3764.80 |
4% |
Industry Pricing
This data is correct as of 9th January 2024. The data shown below is the standard prices listed on the Bio X Cell website and does not include any special offers they may provide from time to time. ichorbio has the same pricing for our academic customers as for our industry customers, whereas Bio X Cell charges a premium to their industry customers.
ichorbio prices are on average 64% lower than the exact same clones from ichorbio, with the highest difference of 77% for the 25mg size.
Size |
ichorbio’s Low Endotoxin antibodies |
Bio X Cell InVivoMAb™ Antibodies |
% Savings |
5mg |
$380 |
$600 |
37% |
25mg |
$1260 |
$2009 |
37% |
50mg |
$2010 |
$3024 |
34% |
100mg |
$2830 |
$4280 |
34% |
ichorbio’s antibodies are 6% less on average for Ultra-Low Endotoxin versions compared with Bio X Cell, with a maximum of 7%.
Size |
ichorbio Ultra Low Endotoxin Antibodies |
Bio X Cell InVivoPlus™ Antibodies |
% Savings |
5mg |
$500 |
$781 |
36% |
25mg |
$1710 |
$2615 |
35% |
50mg |
$2530 |
$3936 |
36% |
100mg |
$3630 |
$5568 |
35% |
In the main all of Bio X Cell’s prices follow a similar pattern as listed above. There are a few exceptions however. Anti CTLA-4 antibody, clone 9D9 anti-CTLA-4 antibody, clone 9H10 anti-PD-L1 antibody, clone 10F.9G2 anti-PD-1 antibody, clone RMP1-14 ichorbio’s Low Endotoxin antibodies are 74% cheaper on average compared to the Bio X Cell’s best selling InVivoMab™ antibodies. The 25mg size is about half the price of the same one from Bio X Cell:
Size |
ichorbio Low Endotoxin antibodies |
Bio X Cell InVivoMAb™ Antibodies |
% Savings |
5mg |
$380 |
$633 |
42% |
25mg |
$1260 |
$2162 |
47% |
50mg |
$2010 |
$3188 |
42% |
100mg |
$2830 |
$4455 |
42% |
ichorbio’s Ultra-Low Endotoxin antibodies are 76% cheaper on average compared to Bio X Cell’s best selling InVivoPlus™ antibodies with the 25mg size 82% less than the same clone from Bio X Cell.
Size |
ichorbio's RMP1-14 Antibody |
Bio X Cell's RMP1-14 Antibody |
% Savings |
5mg |
$500 |
$824 |
39% |
25mg |
$1710 |
$2812 |
39% |
50mg |
$2530 |
$4149 |
39% |
100mg |
$3630 |
$5792 |
37% |
Size |
ichorbio RMP1-14 Antibody |
Bio X Cell RMP1-14 Antibody |
% Savings |
5mg |
$250 |
$633 |
61% |
25mg |
$700 |
$2162 |
68% |
50mg |
$1200 |
$3188 |
62% |
100mg |
$1800 |
$4455 |
60% |
Comparing Bio X Cell to ichorbio: Product Codes
ichorbio has the following comparable products to Bio X Cell:
Bio X Cell Product Code |
Product Description |
ichorbio Cat Number |
ichorbio Product Description |
BE0001-1 |
InVivoMAb anti-mouse CD3ε |
ICH1041 |
|
BE0003-1 |
InVivoMAb anti-mouse CD4 |
ICH1042 |
|
BE0003-2 |
InVivoMAb anti-human CD4 |
ICH1166 |
|
BE0004-1 |
InVivoMAb anti-mouse CD8α |
ICH1044 |
|
BE0005-1 |
InVivoMAb anti-mouse LFA-1α (CD11a) |
ICH1047 |
|
BE0007 |
InVivoMAb anti-mouse/human CD11b |
ICH1049 |
|
BE0011 |
InVivoMAb anti-mouse CD22 |
ICH1181 |
|
BE0014 |
InVivoMAb anti-human CD25 (IL-2Rα) |
ICH1163 |
|
BE0015-1 |
InVivoMAb anti-mouse CD28 |
ICH1055 |
|
BE0019-1 |
InVivoMAb anti-human CD47 |
ICH1014 |
|
BE0020-1 |
InVivoMAb anti-mouse CD54 (ICAM-1) |
ICH1059 |
|
BE0021 |
InVivoMAb anti-mouse L-Selectin (CD62L) |
ICH1060 |
|
BE0024 |
InVivo MAb anti-mouse CD80 (B7-1) |
ICH1037 |
|
BE0025 |
InVivoMAb anti-mouse CD86 (B7-2) |
ICH1038 |
|
BE0031 |
InVivoMAb anti-mouse OX40 (CD134) |
ICH1192 |
|
BE0032 |
InVivoMAb anti-mouse CTLA-4 (CD152) |
ICH1085 |
|
BE0034 |
InVivoMAb anti-mouse LPAM-1 (Integrin α4β7) |
ICH1105 |
|
BE0036 |
InVivoMAb anti-mouse NK1.1 |
ICH1128 |
|
BE0039 |
InVivoMAb anti-mouse/human CD44 |
ICH1115 |
|
BE0045 |
InVivoMAb anti-mouse IL-4 |
ICH1087 |
|
BE0055 |
InVivoMAb anti-mouse IFNγ |
ICH1141 |
|
BE0059 |
InVivoMAb anti-mouse ICOS |
ICH1082 |
|
BE0061 |
InVivoMAb anti-mouse CD8α |
ICH1045 |
|
BE0062 |
InVivoMAb anti-mouse/human Integrin β7 |
ICH1108 |
|
BE0066 |
InVivoMAb anti-mouse Thy1.2 (CD90.2) |
ICH1066 |
|
BE0070 |
InVivoMAb anti-mouse TCR γ/δ |
ICH1035 |
|
BE0071 |
InVivoMAb anti-mouse/human VLA-4 (CD49d) |
ICH1194 |
|
BE0075 |
InVivoMAb anti-mouse Ly6G/Ly6C (Gr-1) |
ICH1131 |
|
BE0079 |
InVivoMAb anti-human MHC Class I (HLA-A, HLA-B, HLA-C) |
ICH1023 |
|
BE0085 |
InVivoMAb mouse IgG2a isotype control |
ICH2245 |
|
BE0086 |
InVivoMAb mouse IgG2b isotype control |
ICH2250 |
|
BE0088 |
InVivoMAb rat IgG1 isotype control |
ICH2246 |
|
BE0089 |
InVivoMAb rat IgG2a isotype control |
ICH2244 |
|
BE0090 |
InVivoMAb rat IgG2b isotype control |
ICH2243 |
|
BE0101 |
InVivoMAb anti-mouse PD-L1 (B7-H1) |
ICH1086 |
|
BE0102 |
InVivoMAb anti-mouse TCRβ |
ICH1153 |
|
BE0108 |
InVivoMAb anti-mouse MHC Class II (I-A/I-E) |
ICH1176 |
|
BE0110 |
InVivoMAb anti-mouse 4-1BBL |
ICH1184 |
|
BE0112 |
InVivoMAb anti-mouse PD-L2 (B7-DC) |
ICH1139 |
|
BE0115 |
InVivoMAb anti-mouse TIM-3 (CD366) |
ICH1133 |
|
BE0117 |
InVivoMAb anti-mouse CD8α |
ICH1043 |
|
BE0119 |
InVivoMAb anti-mouse CD4 |
ICH1210 |
|
BE0121 |
InVivoMAb anti-mouse MHC Class I (H-2Kb) |
ICH1196 |
|
BE0122 |
InVivoMAb anti-rat Kappa Immunoglobulin Light Chain |
ICH1207 |
|
BE0124 |
InVivoMAb anti-mouse CD276 (B7-H3) |
ICH1208 |
|
BE0131 |
InVivoMAb anti-mouse CTLA-4 (CD152) |
ICH1084 |
|
BE0146 |
InVivoMAb anti-mouse PD-1 (CD279) |
ICH1132 |
|
BE0150 |
InVivoMAb anti-mouse CD19 |
ICH1052 |
|
BE0164 |
InVivoMAb anti-mouse CTLA-4 (CD152) |
ICH1096 |
|
BE0168 |
InVivoMAb anti-mouse CTLA-4 (CD152) |
ICH1140 |
|
BE0172 |
InVivoMAb anti-mouse MHC Class I (H-2Kb) |
ICH1142 |
|
BE0174 |
InVivoMAb anti-mouse LAG-3 |
ICH1078 |
|
BE0183 |
InVivoMAb anti-mouse Ter-119 |
ICH1140UL |
|
BE0189 |
InVivoMAb anti-mouse RANKL (CD254) |
ICH1156 |
|
BE0191 |
InVivoMAb anti-mouse RANKL (CD254) |
ICH1114 |
|
BE0213 |
InVivoMAb anti-mouse CSF1R (CD115) |
ICH1068 |
|
BE0218 |
InVivoMAb anti-mouse Galectin-9 |
ICH1186 |
|
BE0220 |
InVivoMAb anti-mouse CD209b (SIGN-R1) |
ICH1077 |
|
BE0223 |
InVivoMAb anti-mouse CD8β (Lyt 3.2) |
ICH1046 |
|
BE0231 |
InVivoMAb anti-human CD3 |
ICH1002 |
|
BE0239 |
InVivoMAb anti-mouse 4-1BB (CD137) |
ICH1036 |
|
BE0241 |
InVivoMAb anti-mouse IFNAR-1 |
ICH1122 |
|
BE0243 |
InVivoMAb anti-mouse IL-1α |
ICH1099 |
|
BE0244 |
InVivoMAb anti-mouse/rat/rabbit TNFα |
ICH1136 |
|
BE0246 |
InVivoMAb anti-mouse/rat IL-1β |
ICH1100 |
|
BE0247 |
InVivoMAb anti-mouse TNFR2 (CD120b) |
ICH1137 |
|
BE0249 |
InVivoMAb anti-mouse CXCR3 (CD183) |
ICH1195 |
|
BE0256 |
InVivoMAb anti-mouse IL-1 R (CD121a) |
ICH1117 |
|
BE0258 |
InVivoMAb anti-mouse IL-21R |
ICH1206 |
|
BE0259 |
InVivoMAb anti-mouse GM-CSF |
ICH1125 |
|
BE0260 |
InVivoMAb Armenian hamster IgG isotype control |
ICH2251 |
|
BE0273 |
InVivoMAb anti-mouse PD-1 (CD279) |
ICH1091 |
|
BE0276 |
InVivoMAb anti-human/monkey CD20 |
ICH1012 |
|
BE0291 |
InVivoMAb anti-human/monkey CD28 |
ICH1013 |
|
BE0299 |
InVivoMAb anti-mouse CD200 (OX2) |
ICH1195 |
|
BE0306 |
InVivoMAb anti-human/monkey MHC class II (HLA-DR) |
ICH1026 |
|
BE0307 |
InVivoMAb anti-mouse CD16/CD32 |
ICH1056 |
|
BE0309 |
InVivoMAb anti-mouse CXCL9 (MIG) |
ICH1204 |
|
BE0311 |
InVivoMAb anti-mouse CD317 (BST2, PDCA-1) |
ICH1205 |
|
BE0312 |
InVivoMAb anti-mouse IFNγ |
ICH1109 |
|
BE0319 |
InVivoMAb anti-mouse FasL (CD178) |
ICH1178 |
|
BE0321 |
InVivoMAb anti-mouse NKG2A/C/E |
ICH1171 |
|
BE0322 |
InVivoMAb anti-mouse CD172a (SIRPα) |
ICH1076 |
|
BE0331 |
InVivoMAb anti-rat/mouse CD71 (TfR1) |
ICH1197 |
|
BE0337 |
InVivoMAb anti-mouse CD96 |
ICH1209 |
|
BE0348 |
InVivoMAb anti-mouse CD27 |
ICH1185 |
|
BE0349 |
RecombiMAb human IgG4 (S228P) isotype control |
ICH2257S228P |
|
BE0360 |
InVivoMAb anti-mouse CD24 |
ICH1192 |
|
BE0378 |
InVivoMAb anti-mouse CD16.2 (FcγRIV) |
ICH1087 |
|
BE0406 |
InVivoMAb anti-human CD2 |
ICH1193 |
|
BP0001-1 |
InVivoPlus anti-mouse CD3ε |
ICH1041UL |
|
BP0003-1 |
InVivoPlus anti-mouse CD4 |
ICH1042UL |
|
BP0004-1 |
InVivoPlus anti-mouse CD8α |
ICH1044UL |
|
BP0036 |
InVivoPlus anti-mouse NK1.1 |
ICH1128UL |
|
BP0045 |
InVivoPlus anti-mouse IL-4 |
ICH1087 |
|
BP0055 |
InVivoPlus anti-mouse IFNγ |
ICH1141UL |
|
BP0057 |
InVivoPlus anti-mouse/human/rat/monkey/hamster/canine/bovine TGF-β |
ICH1090 |
|
BP0061 |
InVivoPlus anti-mouse CD8α |
ICH1045UL |
|
BP0066 |
InVivoPlus anti-mouse Thy1.2 (CD90.2) |
ICH1066UL |
|
BP0075 |
InVivoPlus anti-mouse Ly6G/Ly6C (Gr-1) |
ICH1131UL |
|
BP0101 |
InVivoPlus anti-mouse PD-L1 (B7-H1) |
ICH1086UL |
|
BP0131 |
InVivoPlus anti-mouse CTLA-4 (CD152) |
ICH1084UL |
|
BP0146 |
InVivoPlus anti-mouse PD-1 (CD279) |
ICH1132UL |
|
BP0164 |
InVivoPlus anti-mouse CTLA-4 (CD152) |
ICH1096UL |
|
BP0174 |
InVivoPlus anti-mouse LAG-3 |
ICH1078UL |
|
BP0213 |
InVivoPlus anti-mouse CSF1R (CD115) |
ICH1068UL |
|
BP0241 |
InVivoPlus anti-mouse IFNAR-1 |
ICH1122UL |
|
BP0273 |
InVivoPlus anti-mouse PD-1 (CD279) |
ICH1091UL |
|
CP147 |
RecombiMAb human IgG4 (S228P) isotype control, anti-hen egg lysozyme |
ICH1136 |
|
CP148 |
RecombiMAb human IgG4 S228P L235E P329G (SPLEPG) isotype control, anti-hen egg lysozyme |
ICH2257SPLEPG |
|
CP149 |
RecombiMAb human IgG1 (LALA-PG) isotype control, anti-hen egg lysozyme |
ICH2254LALAPG |
|
CP152 |
RecombiMAb human IgG4 (S228P) isotype control, anti-respiratory syncytial virus |
ICH2257S228P |
|
CP153 |
RecombiMAb anti-mouse PD-1 (CD279) (LALA-PG) |
ICH1182LALAPG |
|
CP161 |
RecombiMAb human IgG1 (LALA-PG) isotype control, anti-respiratory syncytial virus |
ICH2254LALAPG |
|
CP171 |
RecombiMAb human IgG1 (N297A) isotype control, anti-hen egg lysozyme |
ICH2254N297A |
|
CP174 |
RecombiMAb human IgG1 isotype control, anti-hen egg lysozyme |
ICH2254 |
|
SIM0001 |
InVivoSIM anti-human TNFα (Adalimumab Biosimilar) |
ICH4001 |
|
SIM0002 |
InVivoSIM anti-human EGFR (Cetuximab Biosimilar) |
ICH4004 |
|
SIM0003 |
InVivoSIM anti-human PD-1 (Nivolumab Biosimilar) |
ICH4013 |
|
SIM0004 |
InVivoSIM anti-human CTLA-4 (Ipilimumab Biosimilar) |
ICH4025 |
|
SIM0005 |
InVivoSIM anti-human HER2 (Trastuzumab Biosimilar) |
ICH1137 |
|
SIM0006 |
InVivoSIM anti-human TNFα (Infliximab Biosimilar) |
ICH4006 |
|
SIM0007 |
InVivoSIM anti-human VEGF (Bevacizumab Biosimilar) |
ICH4003 |
|
SIM0008 |
InVivoSIM anti-human CD20 (Rituximab Biosimilar) |
ICH2257S228P |
|
SIM0009 |
InVivoSIM anti-human PD-L1 (Atezolizumab Biosimilar) |
ICH4029 |
|
SIM0010 |
InVivoSIM anti-human PD-1 (Pembrolizumab Biosimilar) |
ICH1136UL |
|
SIM0012 |
InVivoSIM anti-human VEGFR-2 (Ramucirumab Biosimilar) |
ICH4032 |
|
SIM0014 |
InVivoSIM anti-human IL-6R (Tocilizumab Biosimilar) |
ICH4012 |
|
SIM0015 |
InVivoSIM anti-human LAG-3 (Relatlimab Biosimilar) |
ICH5117 |
|
SIM0016 |
InVivoSIM anti-human IgE (Omalizumab Biosimilar) |
ICH4010 |
|
SIM0018 |
InVivoSIM anti-human integrin α4β1 (VLA-4) |
ICH4037 |
|
SIM0019 |
InVivoSIM anti-human HER2 (Pertuzumab Biosimilar) |
ICH4030 |
|
SIM0020 |
InVivoSIM anti-human IL-12 p40 (Ustekinumab Biosimilar) |
ICH4034 |
|
SIM0022 |
InVivoSIM anti-human IFNAR1 (Anifrolumab Biosimilar) |
ICH5130 |
|
SIM0023 |
InVivoSIM anti-human IL-4Rα (CD124) (Dupilumab Biosimilar) |
ICH5062 |
|
SIM0024 |
InVivoSIM anti-human integrin α4β7 (LPAM-1) (Vedolizumab Biosimilar) |
ICH4035 |